(Total Views: 371)
Posted On: 02/20/2020 2:21:42 PM
Post# of 148936
CytoDyn Interview to Air on Bloomberg International on the RedChip Money Report
2/20/20, 1:59 PM
VANCOUVER, Washington, Feb. 20, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company"
, a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today an interview with president and chief executive officer Nader Pourhassan, Ph.D., will air on The RedChip Money Report television program. The interview will air Sunday, February 23, at 3 p.m. local time on Bloomberg International, available in 100+ million homes across Europe.
2/20/20, 1:59 PM
VANCOUVER, Washington, Feb. 20, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company"
, a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today an interview with president and chief executive officer Nader Pourhassan, Ph.D., will air on The RedChip Money Report television program. The interview will air Sunday, February 23, at 3 p.m. local time on Bloomberg International, available in 100+ million homes across Europe.
(1)
(0)Scroll down for more posts ▼
